Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Sep 25, 2024
Trial Information
Current as of June 12, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how advance care planning (ACP) can help older adults with lung cancer and their family members make better decisions about life-sustaining treatments. The goal is to improve communication between elderly patients and their designated family decision-makers, ensuring that everyone understands the patient's wishes regarding medical care. In Taiwan, where lung cancer is a leading cause of death among the elderly, this study is particularly important because cultural practices often lead to family-centered decision-making, which can sometimes cause misunderstandings about what the patient really wants.
To participate in this trial, individuals must be at least 60 years old and have been diagnosed with lung cancer. They should be able to communicate clearly, without severe hearing or vision impairments. Additionally, they need to have a family member or friend (the potential agent) who is at least 18 years old and can help make medical decisions in the future. While the trial is currently active, it is not recruiting new participants. Those involved can expect to engage in discussions and activities designed to clarify their preferences for medical treatment, making it easier for everyone to understand and respect their choices.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. lung cancer age ≧ 60
- • 2. The elderly with lung cancer are conscious and have no severe visual or hearing impairment.
- • 3.3. The potential agent is designated by the elderly person with lung cancer who may be a family member who may make medical decisions in the future. The potential agent must be at least 18 years old.
- Exclusion Criteria:
- • 1. People with severe hearing loss and visual impairment who are unable to communicate in Mandarin and Taiwanese.
- • 2. The potential agent is under 18 years old
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported